Your browser doesn't support javascript.
loading
A Chemiluminescent Probe for HNO Quantification and Real-Time Monitoring in Living Cells.
An, Weiwei; Ryan, Lucas S; Reeves, Audrey G; Bruemmer, Kevin J; Mouhaffel, Lyn; Gerberich, Jeni L; Winters, Alexander; Mason, Ralph P; Lippert, Alexander R.
Afiliación
  • An W; Department of Chemistry, Center for Drug Discovery, Design, and Delivery (CD4), and, Center for Global Health Impact (CGHI), Southern Methodist University, Dallas, TX, 75205-0314, USA.
  • Ryan LS; Department of Chemistry, Center for Drug Discovery, Design, and Delivery (CD4), and, Center for Global Health Impact (CGHI), Southern Methodist University, Dallas, TX, 75205-0314, USA.
  • Reeves AG; Department of Chemistry, Center for Drug Discovery, Design, and Delivery (CD4), and, Center for Global Health Impact (CGHI), Southern Methodist University, Dallas, TX, 75205-0314, USA.
  • Bruemmer KJ; Department of Chemistry, Center for Drug Discovery, Design, and Delivery (CD4), and, Center for Global Health Impact (CGHI), Southern Methodist University, Dallas, TX, 75205-0314, USA.
  • Mouhaffel L; Department of Chemistry, Center for Drug Discovery, Design, and Delivery (CD4), and, Center for Global Health Impact (CGHI), Southern Methodist University, Dallas, TX, 75205-0314, USA.
  • Gerberich JL; Prognostic Imaging Research Laboratory (PIRL), Pre-clinical Imaging Section, Department of Radiology, UT Southwestern Medical Center, Dallas, TX, 75390-9058, USA.
  • Winters A; Prognostic Imaging Research Laboratory (PIRL), Pre-clinical Imaging Section, Department of Radiology, UT Southwestern Medical Center, Dallas, TX, 75390-9058, USA.
  • Mason RP; Prognostic Imaging Research Laboratory (PIRL), Pre-clinical Imaging Section, Department of Radiology, UT Southwestern Medical Center, Dallas, TX, 75390-9058, USA.
  • Lippert AR; Department of Chemistry, Center for Drug Discovery, Design, and Delivery (CD4), and, Center for Global Health Impact (CGHI), Southern Methodist University, Dallas, TX, 75205-0314, USA.
Angew Chem Int Ed Engl ; 58(5): 1361-1365, 2019 01 28.
Article en En | MEDLINE | ID: mdl-30476360
Azanone (HNO) is a reactive nitrogen species with pronounced biological activity and high therapeutic potential for cardiovascular dysfunction. A critical barrier to understanding the biology of HNO and furthering clinical development is the quantification and real-time monitoring of its delivery in living systems. Herein, we describe the design and synthesis of the first chemiluminescent probe for HNO, HNOCL-1, which can detect HNO generated from concentrations of Angeli's salt as low as 138 nm with high selectivity based on the reaction with a phosphine group to form a self-cleavable azaylide intermediate. We have capitalized on this high sensitivity to develop a generalizable kinetics-based approach, which provides real-time quantitative measurements of HNO concentration at the picomolar level. HNOCL-1 can monitor dynamics of HNO delivery in living cells and tissues, demonstrating the versatility of this method for tracking HNO in living systems.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Imagen Óptica / Colorantes Fluorescentes / Óxidos de Nitrógeno Límite: Animals / Humans Idioma: En Revista: Angew Chem Int Ed Engl Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Imagen Óptica / Colorantes Fluorescentes / Óxidos de Nitrógeno Límite: Animals / Humans Idioma: En Revista: Angew Chem Int Ed Engl Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos